Organon & Co.

Organon & Co. OGN

Dividend Summary

The next Organon & Co. dividend is expected to go ex in 26 days and to be paid in 2 months.
The previous Organon & Co. dividend was 28c and it went ex 2 months ago and it was paid 1 month ago.
There are typically 4 dividends per year (excluding specials), and the dividend cover is approximately 2.0.

Latest Dividends
Summary Previous dividend Next dividend
Status Paid Forecast
Type Quarterly Quarterly
Per share 28c Sign Up Required
Declaration date 15 Feb 2024 (Thu) 02 May 2024 (Thu)
Ex-div date 23 Feb 2024 (Fri) 10 May 2024 (Fri)
Pay date 14 Mar 2024 (Thu) 13 Jun 2024 (Thu)

Enter the number of Organon & Co. shares you hold and we'll calculate your dividend payments:

Previous Payment
Next Payment
Forecast Accuracy
100%
Our premium tools have predicted Organon & Co. with 100% accuracy.
Dividend Yield Today
6.4%
The dividend yield is calculated by dividing the annual dividend payment by the prevailing share price
The table below shows the full dividend history for Organon & Co.
Status Type Decl. date Ex-div date Pay date Decl. Currency Forecast amount Decl. amount Accuracy
Forecast Quarterly 27 Apr 2028 08 May 2028 08 Jun 2028 USD Sign up
Forecast Quarterly 10 Feb 2028 21 Feb 2028 09 Mar 2028 USD Sign up
Forecast Quarterly 28 Oct 2027 08 Nov 2027 09 Dec 2027 USD Sign up
Forecast Quarterly 03 Aug 2027 13 Aug 2027 09 Sep 2027 USD Sign up
Forecast Quarterly 29 Apr 2027 10 May 2027 10 Jun 2027 USD Sign up
Forecast Quarterly 11 Feb 2027 22 Feb 2027 11 Mar 2027 USD Sign up
Forecast Quarterly 29 Oct 2026 09 Nov 2026 10 Dec 2026 USD Sign up
Forecast Quarterly 04 Aug 2026 14 Aug 2026 10 Sep 2026 USD Sign up
Forecast Quarterly 30 Apr 2026 11 May 2026 11 Jun 2026 USD Sign up
Forecast Quarterly 12 Feb 2026 23 Feb 2026 12 Mar 2026 USD Sign up
Forecast Quarterly 30 Oct 2025 10 Nov 2025 11 Dec 2025 USD Sign up
Forecast Quarterly 05 Aug 2025 15 Aug 2025 11 Sep 2025 USD Sign up
Forecast Quarterly 01 May 2025 12 May 2025 12 Jun 2025 USD Sign up
Forecast Quarterly 13 Feb 2025 24 Feb 2025 13 Mar 2025 USD Sign up
Forecast Quarterly 31 Oct 2024 11 Nov 2024 12 Dec 2024 USD Sign up
Forecast Quarterly 06 Aug 2024 16 Aug 2024 12 Sep 2024 USD Sign up
Forecast Quarterly 02 May 2024 10 May 2024 13 Jun 2024 USD Sign up
Paid Quarterly 15 Feb 2024 23 Feb 2024 14 Mar 2024 USD 28c 28c 😄
Paid Quarterly 02 Nov 2023 10 Nov 2023 14 Dec 2023 USD 28c 28c 😄
Paid Quarterly 08 Aug 2023 17 Aug 2023 14 Sep 2023 USD 28c 28c 😄
Paid Quarterly 04 May 2023 12 May 2023 15 Jun 2023 USD 28c 28c 😄
Paid Quarterly 16 Feb 2023 24 Feb 2023 16 Mar 2023 USD 28c 28c 😄
Paid Quarterly 03 Nov 2022 10 Nov 2022 15 Dec 2022 USD 28c 28c 😄
Paid Quarterly 04 Aug 2022 12 Aug 2022 15 Sep 2022 USD 28c 28c 😄
Paid Quarterly 05 May 2022 13 May 2022 16 Jun 2022 USD 28c 28c 😄
Paid Quarterly 17 Feb 2022 25 Feb 2022 17 Mar 2022 USD 28c 28c 😄
Paid Quarterly 11 Nov 2021 19 Nov 2021 16 Dec 2021 USD 28c 28c 😄
Paid Quarterly 12 Aug 2021 20 Aug 2021 13 Sep 2021 USD 28c
Year Amount Change
2006 0.0c
2007 0.0c
0%
2008 0.0c
0%
2009 0.0c
0%
2010 0.0c
0%
2011 0.0c
0%
2012 0.0c
0%
2013 0.0c
0%
2014 0.0c
0%
2015 0.0c
0%
2016 0.0c
0%
2017 0.0c
0%
2018 0.0c
0%
2019 0.0c
0%
2020 0.0c
0%
2021 112.0c
100%
2022 112.0c
0%
2023 112.0c
0%
2024 Sign Up Required
2025 Sign Up Required
2026 Sign Up Required
2027 Sign Up Required

Organon & Co. Optimized Dividend Chart

The chart below shows the optimized dividends for this security over a rolling 12-month period.
Dividend Yield Today
6.4%
Optimized Yield
Sign Up Required
52 Week High
14.7% on 09 November 2023
52 Week Low
5.1% on 17 August 2023
Next Ex-Div-Date Countdown
Sign Up Required

About Organon & Co.

Organon & Co. is a science-based global pharmaceutical company. The Company is engaged in developing and delivering health solutions through a portfolio of prescription therapies within women’s health, biosimilars and established brands. Its women's health portfolio includes Nexplanon or Implanon NXT, which is a patented long-acting reversible contraceptive. Its operating segments include the Organon Products segment. The Organon Products segment is engaged in developing and delivering health solutions through its portfolio of prescription therapies within women’s health, biosimilars, and established brands. The Company's products segment portfolio includes: Women’s Health, Biosimilars and Established Brands. Women’s Health contains contraception and fertility brands, such as Nexplanon or Implanon NXT, NuvaRing and elonva. The Company's Biosimilars portfolio consists of three immunology products: Brenzys, Renflexis and Hadlima; and two oncology products: Ontruzant and Aybintio.

Sector
Pharmaceuticals & Biotechnology
Country
United States
Share Price
$17.45 (yesterday's closing price)
Shares in Issue
256 million
Market Cap
$4.5bn
Dividend Cover
How many times is the dividend covered by company income. A cover of 1 means all income is paid out in dividends
2.0
CADI
The Consecutive Annual Dividend Increases - the number of years this company has been increasing its dividends
0
Market Indices
S&P 500
No articles found